0 0 Chemicalname=3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester,3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester,CAS=CAS=1421773-36-5Molecular formula=C18H27BFNO4 | CLEARSYNTH

3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester

BORON DERIVATIVES

Product Details

CAT No.# CS-AW-00085
Category Boron Derivatives
CAS 1421773-36-5
Molecular Weight 351.22
Molecular Formula C18H27BFNO4
Purity: >98%
Synonyms: tert-butyl N-{[3-fluoro-5-(tetramethyl-1,3,2- dioxaborolan-2-yl)phenyl]methyl}carbamate
References: NA
Shipping: Free Shipping for worldwide on order above 2000 USD
3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester Worldwide Suppliers of 3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester Boron Derivatives Clearsynth CS-AW-00085

Product rating: 9 3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester based on 20 ratings

  1. Boron Derivatives
  2. 3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)




This page contains information about 3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester Cas 1421773-36-5 and its Boron Derivatives.

3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester 3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester Worldwide Suppliers of 3-(Boc-aminomethyl)-5-fluorobenzeneboronic acid pinacol ester Boron Derivatives Clearsynth 1421773-36-5

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."